2m 2m 2m 2m 2m 2m 2m
Zai Lab Sp ADR (ZLAB)
NASDAQ
$18.44-$0.05 (-0.24%)
Price as of Jun 23, 2026 2:47 PM EDT- $2.1BMarket Cap
- -48.68%1-Year Change
- BiotechnologyIndustry
Zai Lab Sp ADR (ZLAB)
$18.44-$0.05 (-0.24%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 460.2M +15.33% | 399.0M +49.59% | 266.7M +24.03% | 215.0M +49.01% | |
Cost of Revenue | 190.5M +29.50% | 147.1M +53.54% | 95.8M +29.45% | 74.0M +41.69% | |
Gross Profit | 269.6M +7.05% | 251.9M +47.38% | 170.9M +21.19% | 141.0M +53.16% | |
Sales and Marketing Expense | 277.6M -7.08% | 298.7M +6.08% | 281.6M +8.74% | 259.0M +18.34% | |
Research and Development Expense | -220.9M -5.80% | -234.5M -11.80% | -265.9M -7.17% | -286.4M -50.04% | |
Depreciation and Amortization Expense | 15.0M +26.60% | 11.9M +31.31% | 9.0M +9.75% | 8.2M +26.82% | |
Total Operating Expenses | 190.5M +29.50% | 147.1M -47.76% | 281.6M +8.74% | 259.0M +18.34% | |
Operating Profit | -229.4M -18.67% | -282.1M -23.04% | -366.6M -9.34% | -404.4M -42.24% | |
Interest Income | 33.0M -10.93% | 37.1M -6.76% | 39.8M +172.92% | 14.6M +565.84% | |
Interest Expense | N/A N/A | -2.3M N/A | N/A N/A | 0 N/A | |
Interest Income and Expense and Net | 33.0M -5.17% | 34.9M -12.43% | 39.8M +172.92% | 14.6M +565.84% | |
Total Nonoperating Income and Expense | 3.5M -33.21% | 5.3M -24.35% | 7.0M +125.06% | 3.1M +156.19% | |
Income before Taxes | -178.5M -30.59% | -257.1M -23.17% | -334.6M -24.48% | -443.1M -37.01% | |
Income Taxes | -2.9M N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -175.5M -31.73% | -257.1M -23.17% | -334.6M -24.51% | -443.3M -37.08% | |
Net Income from Continuing Operations Applicable to Common | -178.5M -30.59% | -257.1M -23.17% | -334.6M -24.51% | -443.3M -37.08% | |
Basic EPS and Net Income | -0.16 -38.46% | -0.26 -25.71% | -0.35 -23.91% | -0.46 -93.93% | |
Diluted EPS and Net Income | -0.16 -38.46% | -0.26 -25.71% | -0.35 -23.91% | -0.46 -93.93% | |
Basic Weighted Average Shares | 1.1B +10.70% | 989.5M +2.39% | 966.4M +0.87% | 958.1M +930.27% | |
Diluted Weighted Average Shares | 1.1B +10.70% | 989.5M +2.39% | 966.4M +0.87% | 958.1M +930.27% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 679.6M +51.13% | 449.7M -43.09% | 790.2M -21.65% | 1.0B +4.60% | |
Short-Term Investments | 10.0M -96.97% | 330.0M +1,924.54% | 16.3M N/A | 0 -100.00% | |
Cash and Cash Equivalents and Short-Term Investments | 689.6M -11.56% | 779.7M -3.32% | 806.5M -20.03% | 1.0B -28.43% | |
Total Current Assets | 1.0B -2.97% | 1.1B +11.80% | 939.6M -16.43% | 1.1B -25.09% | |
Accumulated Depreciation | 42.2M +13.59% | 37.1M +23.17% | 30.1M +36.58% | 22.1M +34.33% | |
Property and Plant and Equipment and Net | 47.4M -1.19% | 48.0M -10.74% | 53.7M -7.14% | 57.9M +34.25% | |
Total Long-Term Assets | 3.1M -93.63% | 48.0M -10.74% | 53.7M -7.14% | 57.9M +34.25% | |
Total Assets | 1.2B -1.13% | 1.2B +14.42% | 1.0B -15.07% | 1.2B -24.21% | |
Income Taxes Payable | 5.3M +2.89% | 5.2M -69.66% | 17.0M +27.89% | 13.3M +50.65% | |
Total Short-Term Debt | 204.5M +55.29% | 131.7M N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 416.2M +39.01% | 299.4M +47.43% | 203.1M +45.21% | 139.8M -27.51% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 0 -100.00% | 325,000 0.00% | 325,000 -99.06% | 34.7M +261.00% | |
Total Liabilities | 456.9M +32.49% | 344.9M +43.58% | 240.2M +37.60% | 174.5M -24.11% | |
Retained Earnings | -2.6B +7.16% | -2.5B +11.71% | -2.2B +17.98% | -1.9B +31.26% | |
Total Stockholders Equity | 715.5M -14.91% | 840.9M +5.62% | 796.1M -23.86% | 1.0B -24.23% | |
Total Shares Outstanding | 1.1B +2.66% | 1.1B +10.85% | 972.2M +1.25% | 960.2M +905.08% | |
Cash Flow | |||||
Cash from Operating Activities | -150.8M -29.82% | -214.9M +8.42% | -198.2M -46.09% | -367.6M -33.06% | |
Capital Expenditures | 8.1M +43.20% | 5.7M -21.56% | 7.2M -70.67% | 24.6M +34.38% | |
Cash from Investing Activities | 307.9M +182.06% | -375.2M +3,381.75% | -10.8M -102.57% | 420.0M +68.04% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 72.4M -79.32% | 349.9M +5,538.97% | -6.4M +271.85% | -1.7M -100.21% | |
Financials Ratio | |||||
Gross Margin | 58.60% -7.18% | 63.13% -1.48% | 64.08% -2.29% | 65.58% +2.79% | |
Operating Margin | -49.86% -29.48% | -70.71% -48.55% | -137.44% -26.91% | -188.04% -61.24% | |
Return on Assets | -14.89% -35.67% | -23.14% -21.98% | -29.66% -5.32% | -31.33% -35.35% | |
Return on Equity | -22.56% -28.19% | -31.41% -13.56% | -36.34% -0.58% | -36.55% -33.86% | |
Revenue Growth | 15.33% -69.09% | 49.59% +106.35% | 24.03% -50.96% | 49.01% -74.84% | |
Current Ratio | 2.45 -30.20% | 3.51 -24.17% | 4.63 -42.45% | 8.04 +3.33% | |
Cash Ratio | 1.63 +8.72% | 1.50 -61.40% | 3.89 -46.04% | 7.21 +44.29% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow